Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) shares, rose in value on Friday, March 07, with the stock price up by 0.80% to the previous day’s close as strong demand from buyers drove the stock to $331.41.
Actively observing the price movement in the last trading, the stock closed the session at $328.77. Referring to stock’s 52-week performance, its high was $377.46, and the low was $189.00. On the whole, MDGL has fluctuated by -2.52% over the past month.
With the market capitalization of Madrigal Pharmaceuticals Inc currently standing at about $7.32 billion, investors are eagerly awaiting this quarter’s results, scheduled for in April.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 586.19M, with a low estimate of 107.23M and a high estimate of 132M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 114.12M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MDGL’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of MDGL currently trading nearly -1.20% and 2.26% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 50.17, while the 7-day volatility ratio is showing 7.46% which for the 30-day chart, stands at 5.48%. Furthermore, Madrigal Pharmaceuticals Inc (MDGL)’s beta value is -0.72, and its average true range (ATR) is 20.78.
A comparison of Madrigal Pharmaceuticals Inc (MDGL) with its peers suggests the former has fared considerably weaker in the market. MDGL showed an intraday change of 0.80% in last session, and over the past year, it grew by 33.37%%.
Data on historical trading for Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) indicates that the trading volumes over the past 3 months, they’ve averaged 406.51K. According to company’s latest data on outstanding shares, there are 22.00 million shares outstanding.
Nearly 15.96% of Madrigal Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 104.02% of the company’s shares. The stock has risen by 7.40% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MDGL stock heading into the next quarter.
